Paragon Bioservices, the leading private equity-backed, biologics contract development and manufacturing organization (CDMO) announced today the appointment of Thomas VanCott, Ph.D., as Chief Technology and Strategy Officer (CTSO), along with several key promotions and new hires.
{iframe}https://paragonbioservices.com/paragon-bioservices-appoints-new-ctso/{/iframe}